Incidence of Invasive Fungal Disease in Patients Receiving Immunosuppressive Therapy, Intensive Chemotherapy or Reduced Intensity Haematopoietic Stem Cell Transplantation on Posaconazole Prophylaxis
Phase of Trial: Phase IV
Latest Information Update: 14 Jun 2017
At a glance
- Drugs Posaconazole (Primary)
- Indications Mycoses
- Focus Therapeutic Use
- Acronyms KIASII
- 07 Jun 2017 Status changed from not yet recruiting to recruiting.
- 18 Oct 2016 Planned End Date changed from 1 Sep 2018 to 1 Nov 2018.
- 18 Oct 2016 Planned primary completion date changed from 1 Sep 2018 to 1 Nov 2018.